These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6483934)

  • 21. Metabolism of 3H-dopamine continuously perfused through push-pull cannulas in rats' brains: modification by amphetamine or prostaglandin F2 alpha.
    Nielsen JA; Fossom LH; Sparber SB
    Pharmacol Biochem Behav; 1980 Aug; 13(2):235-42. PubMed ID: 7413695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Super-reactivity to amphetamine toxicity induced by schedule of reinforcement.
    Valencia-Flores M; Velázquez-Martínez DN; Villarreal JE
    Psychopharmacology (Berl); 1990; 102(1):136-44. PubMed ID: 2392502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent and baseline-dependent conditioning with d-amphetamine in the place conditioning paradigm.
    Costello NL; Carlson JN; Glick SD; Bryda M
    Psychopharmacology (Berl); 1989; 99(2):244-7. PubMed ID: 2508162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate and d-amphetamine: effects and interactions with alphamethyltyrosine and tetrabenazine on DRL performance in rats.
    Seiden LS; Andresen J; MacPhail RC
    Pharmacol Biochem Behav; 1979 Apr; 10(4):577-84. PubMed ID: 572553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
    Andrews JS; Holtzman SG
    Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C
    Pharmacol Res; 1998 Nov; 38(5):333-7. PubMed ID: 9806811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
    Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM
    J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analyses of the effects of d-amphetamine on fixed-interval schedule performances of rats.
    McAuley F; Leslie JC
    J Exp Anal Behav; 1986 Mar; 45(2):207-19. PubMed ID: 3958666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of fenfluramine on schedule-induced drinking in rats.
    Sanger DJ
    Pharmacol Biochem Behav; 1979 Aug; 11(2):151-3. PubMed ID: 504294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cocaine and d-amphetamine on behavior maintained under various schedules of food presentation in squirrel monkeys.
    Gonzalez FA; Goldberg SR
    J Pharmacol Exp Ther; 1977 Apr; 201(1):33-43. PubMed ID: 403281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of generalization of nisoxetine with amphetamine in the rat.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1085-8. PubMed ID: 3265789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of behavioural mechanisms involved in the acquisition of amphetamine anorectic tolerance.
    Demellweek C; Goudie AJ
    Psychopharmacology (Berl); 1983; 79(1):58-66. PubMed ID: 6403966
    [No Abstract]   [Full Text] [Related]  

  • 34. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of d-amphetamine and caffeine on schedule-controlled and schedule-induced responding.
    McMillan DE
    J Exp Anal Behav; 1979 Nov; 32(3):445-56. PubMed ID: 512573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of microinjection of d-amphetamine into the n. accumbens during the late maintenance phase of an ethanol consumption bout.
    Samson HH; Chappell A; Slawecki C; Hodge C
    Pharmacol Biochem Behav; 1999 May; 63(1):159-65. PubMed ID: 10340537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of various psychoactive drugs on the in vivo metabolism of d-amphetamine in the rat.
    Lewander T
    Eur J Pharmacol; 1969 Apr; 6(1):38-44. PubMed ID: 5784646
    [No Abstract]   [Full Text] [Related]  

  • 38. d-Amphetamine, operant history, and variable-interval performance.
    Poling A; Krafft K; Chapman L
    Pharmacol Biochem Behav; 1980 Apr; 12(4):559-62. PubMed ID: 7393953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in rat.
    Howard JL; Pollard GT; Craft RM; Rohrbach KW
    Pharmacol Biochem Behav; 1987 May; 27(1):165-9. PubMed ID: 3615538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interresponse time changes as a function of water deprivation and amphetamine.
    Brown BM; Seiden LS
    J Pharmacol Exp Ther; 1975 May; 193(2):701-12. PubMed ID: 1142113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.